Palatin Technologies (PTN) Return on Sales (2010 - 2026)
Palatin Technologies' (PTN) quarterly Return on Sales came in at 0.0% in Q1 2026, up 66.0% YoY from 0.0% in Q1 2025, and up 99.42% on a QoQ basis from 0.63% in Q4 2025.
Palatin Technologies (PTN) Return on Sales (2010 - 2026) Analysis & Trends
Palatin Technologies (PTN) has 16 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.
- Quarterly Return on Sales rose 66.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (up 66.0% YoY) and the FY2024 annual result came in at 0.07%, down 2.0% from the prior year.
- Return on Sales rose to 0.0% in Q1 2026, from 0.63% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.01% in Q3 2025 to a low of 0.77% in Q4 2024.
- A 5-year average of 0.21% and a median of 0.09% in 2022 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2024 — Return on Sales plunged 73 bps — and 2026, when it soared 66 bps.
- Tracing PTN's Return on Sales over 5 years: stood at 0.06% in 2022, then surged by 40 bps to 0.04% in 2023, then tumbled by 1898 bps to 0.77% in 2024, then advanced by 19 bps to 0.63% in 2025, then jumped by 99 bps to 0.0% in 2026.
- The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.63% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Palatin Technologies | 40.86 Mn | 40.86 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | -0.63% |
| Sep 30, 2025 | 0.01% |
| Mar 31, 2025 | -0.67% |
| Dec 31, 2024 | -0.77% |
| Sep 30, 2024 | -0.14% |
| Jun 30, 2024 | -0.24% |
| Mar 31, 2024 | -0.04% |
| Dec 31, 2023 | -0.04% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -0.07% |
| Dec 31, 2022 | -0.06% |
| Sep 30, 2022 | -0.10% |
| Jun 30, 2022 | -0.25% |
| Mar 31, 2022 | -0.35% |
| Dec 31, 2021 | -0.27% |
| Sep 30, 2021 | -0.46% |
| Jun 30, 2021 | -0.16% |
| Mar 31, 2021 | -0.91% |